Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Sleep apnea is a common and serious sleep disorder that causes a person to stop breathing during sleep. It’s a potentially fatal condition, with harmful short- and long-term complications, that affects more than 1 in 3 men and 1 in 6 women. As stated by National Sleep Foundation, more than 18 million American adults are suffering from sleep apnea. It occurs in all age groups and in both male and female. Undiagnosed or untreated sleep apnea can lead to serious complications such as heart attack, glaucoma, diabetes, cancer, and cognitive and behavioural disorders.
Further, as per Sleep Apenea Organisation, more than 22 million Americans suffer from sleep apnea. Whereas, 80 percent of the cases of moderate and severe obstructive sleep apnea are undiagnosed. Untreated sleep apnea can lead to high blood pressure, chronic heart failure, atrial fibrillation, stroke, and other cardiovascular problems. Further, it is associated with type 2 diabetes and depression, and is a factor in many traffic accidents and accidents with heavy machinery, owing to the persistent drowsiness suffered by many sleep apnea patients before the disease is recognized and treated.
The demand for sleep apnea devices has witnessed rapid increase during the past few years. This increase has been mainly triggered by the exponential growth in the prevalence of sleep apnea. In additional, technological developments coupled with the initiatives by market players, the government to increase awareness regarding sleep apnea, and the various technological advancements brought about by players to make the products comfortable for patients boost the growth of the market.
For instance, in May 2017, Fisher & Paykel launched the advanced F&P SleepStyle CPAP Device which are developed for the usage in the diagnosis and treatment of sleep specialists and obstructive sleep apnea patients. On flip side, availability of alternate methods in the market acts as a major barrier for the sleep apnea Market
There are many alternatives that are present in the market to treat sleep apnea.
Moreover, rising focus on home health and growing preference for home sleep testing is likely to offer growth opportunities during the forecast period.
The report analyses the global sleep apnea devices market based on diagnostic devices, therapeutic devices, end user and geography.
Sleep apnea devices market by diagnostic devices type is segmented into Polysomnography Devices (PSG), Pulse Oximeters, Actigraphy Devices and others.
Insights in these diagnostic devices type, the pulse oximeters is widely used diagnostic device. Pulse oximeter is simple test that can easily be done at home since it provides basic information in evaluating whether a person has one of the more common sleep disorders. The lucrative growth of this segment is attributed to its easy and inexpensive application as well as the availability of these devices at online platforms.
The sleep apnea devices market by therapeutic devices by Positive Airway Pressure (PAP) Devices, Adaptive Servo Ventilation (ASV) Devices, Oxygen Devices, Oral Appliances and Masks & Accessories. Positive Airway Pressure (PAP) Devices by is further segmented into continuous positive airway pressure (CPAP) devices, bi-level positive airway pressure (BiPAP) devices and auto positive airway pressure (APAP). Further, the oxygen devices are sub categorised into oxygen concentrators, portable oxygen concentrators and liquid portable oxygen.
Auto positive airway pressure device enables the flow of pressured air through the airways of the respiratory tract through a face mask which is attached to a tube and a machine thus, ensuring normal breathing during sleep. Rising efforts in miniaturization of these devices coupled with availability of customization options with additional features is anticipated to propel market growth during the forecast period.
By end user, the sleep apnea devices market is segmented into sleep laboratories & hospitals and home care. The home care segment of the market is anticipated to observe lucrative growth during the forecast period owing to the preference for home care in sleep apnea diagnosed patients.
By region, the sleep apnea diagnostic devices market is segmented into North America, Europe, Asia Pacific, and the Rest of the world.
Geographically, North America held the largest market share of the sleep apnea devices market in 2018. This regional growth of the North America is mainly attributed to the rising incidence of sleep disorders and growing initiatives by the government and non-government organizations for increasing awareness about sleep disorders and sleep hygiene. Numerous government organisation is running awareness programs to educate people and medical practitioners about healthy sleep habits. Furthermore, the North American market is characterized by the presence of several sleep specialists and the major players in the regional market are investing huge capital to develop technologically efficient, effective, and easy to use sleep apnea devices.
Asia Pacific is expected to grow at the highest CAGR during the forecast period. The high growth in this region is attributed to the owing to increasing prevalence of sleep apnea disorders, the large undiagnosed pool in countries such as India, and initiatives by the government & other private organizations to raise awareness regarding sleep disorders
March 2018 – Nihon Kohden, announced the commercial launch of NKHiQTM Wireless Patient Monitoring System. It is a smart, secure data acquisition and management platform that leverages Wi-Fi technology to provide safe continuous patient monitoring in the hospital setting.
February 2019 - Oventus Medical Ltd, launched O2Vent(R) Optima device in Canada. The device can treat both the potentially fatal condition, obstructive sleep apnoea (OSA) and snoring. The device launch in Canada follows the successful completion of a controlled market release, with early results demonstrating strong patient acceptance.
October 2018– Beddr, launched Sleep Tuner, a forehead-worn sensor for sleep apnea patients. The device senses blood oxygenation, heart rate, sleep position, and stopped breathing events.
May 2017- Fisher & Paykel Healthcare Corporation, launched the F&P SleepStyle device. It is a CPAP device used in the treatment of obstructive sleep apnea (OSA).
The major market players in the sleep apnea devices market include ResMed, Inc., Koninklijke Philips, and Fisher & Paykel Healthcare Ltd. Other players in the sleep apnea diagnostic devices market include SomnoMed Ltd., Compumedics Limited, Löwenstein Medical GmbH & Co. KG., Whole You, Inc., BMC Medical Co., Ltd., Drive DeVilbiss Healthcare, and Braebon Medical Corporation.
